Alzheimer’s Disease remains one of the most pressing challenges in healthcare, with new treatments and research breakthroughs reshaping the landscape of care. This episode dives into the latest advancements, including current medications, clinical trials, and emerging therapies that pharmacists need to know. Stay informed and ready to support patients and caregivers—tune in to expand your expertise and navigate this evolving field with confidence.

Upon successful completion of this course, learners should be able to:
1. Describe the current treatment options for Alzheimer’s Disease.
2. Identify key considerations for pharmacists when counseling patients and caregivers on Alzheimer’s Disease management and emerging therapies.

Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

James Hoehns, PharmD, BCPS
Clinical Professor
University of Iowa

Joshua Davis Kinsey has no relevant financial relationships to disclose. 

James Hoehns is a Sub-Investigator/ Research for Eli Lilly. All relevant financial relationships have been mitigated.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: February 24, 2025
Planned Expiration Date: February 24, 2026

Copyright 2025, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.